with orphan drug status your time line doesn’t quite seem right but the big thing for me re your time line
Is how long did it take for MSB to get too 3 phase two trials and does MSB still have to go threw phase 1 trials for each product they wish to bring to market ?
and ultimately at what price will that be ? Cause you can have the best drug in world but if you can’t afford it then what’s the point and as CYP are targeting of the shelf products price will determine how many will actually buy it Not who got their first
GLTA
PS every morning I watch for the TH come on baby I’m ready to retire
2020 - A Year Full Of Potentials, page-157
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.0¢ | 24.5¢ | $19.72K | 78.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31298 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 39430 | 1 |
View Market Depth
| Last trade - 15.59pm 09/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |